VasoDynamics strengthens management team with key appointments Gallery VasoDynamics strengthens management team with key appointments By Chloe Atkinson|2024-05-16T22:58:13+00:00August 1st, 2023|Uncategorized| Read More
First dose cohort completed and enrolment to second dose cohort commenced in NG11-2 Phase-Ib clinical trial Gallery First dose cohort completed and enrolment to second dose cohort commenced in NG11-2 Phase-Ib clinical trial By Chloe Atkinson|2024-05-16T22:58:19+00:00July 28th, 2023|Uncategorized| Read More
First patient dosed for the first week in NG11-2 Phase Ib clinical trial Gallery First patient dosed for the first week in NG11-2 Phase Ib clinical trial By Chloe Atkinson|2024-05-16T22:58:36+00:00May 26th, 2023|Uncategorized| Read More
First patient enrolled in NG11-2 Phase Ib clinical trial Gallery First patient enrolled in NG11-2 Phase Ib clinical trial By Chloe Atkinson|2024-05-16T22:58:42+00:00May 8th, 2023|Uncategorized| Read More
VasoDynamics Receives Global Health & Pharma Biotechnology 2023 Award Gallery VasoDynamics Receives Global Health & Pharma Biotechnology 2023 Award By Chloe Atkinson|2024-05-16T22:58:50+00:00April 12th, 2023|Uncategorized| Read More
VasoDynamics Receives UK MHRA-REC Approval On NG11-2 Phase Ib Clinical Trial Gallery VasoDynamics Receives UK MHRA-REC Approval On NG11-2 Phase Ib Clinical Trial By Chloe Atkinson|2024-05-16T22:58:56+00:00January 24th, 2023|Uncategorized| Read More
VasoDynamics files UK patent for Radiotherapy-Induced Oral Mucositis (RIOM) Clinical Trial Methodology Gallery VasoDynamics files UK patent for Radiotherapy-Induced Oral Mucositis (RIOM) Clinical Trial Methodology By Chloe Atkinson|2024-05-16T22:59:02+00:00December 22nd, 2022|Uncategorized| Read More
VasoDynamics submits UK Clinical Trial Application for NG11-2 Gallery VasoDynamics submits UK Clinical Trial Application for NG11-2 By Chloe Atkinson|2024-05-16T22:59:07+00:00October 21st, 2022|Uncategorized| Read More
VasoDynamics establishes Clinical and Scientific Advisory Board Gallery VasoDynamics establishes Clinical and Scientific Advisory Board By Chloe Atkinson|2024-05-16T22:59:12+00:00July 30th, 2022|Uncategorized| Read More
VasoDynamics selects clinical trial sites across the UK and appoints Chief Investigator Gallery VasoDynamics selects clinical trial sites across the UK and appoints Chief Investigator By Chloe Atkinson|2024-05-16T22:59:17+00:00June 30th, 2022|Uncategorized| Read More